Posted on Facebook by Chris Jolley on 10/20/20 Originally posted by Kelly Lewler
The United States Drug Enforcement Administration and Prescription Opioid Production Quotas: An End Game of Eradication?
Up to this point, reports of APQ reduction-related shortages of oral opioids are only anecdotal, with numerous reports from patients on social media. In these cases, the patients (generally suffering from chronic non-cancer pain) report that their pharmacies have “run out” of medications that they have taken for many years, although these patients have not been privy to whether these lacks of availability are due to APQ reductions or other supply-side issues within their own pharmacies. Irrespective this has the potential of creating a dangerous bias against legitimate opioid patients who may have to go to multiple pharmacies and travel great distances for needed medications.
The United States Drug Enforcement Administration and Prescription Opioid Production Quotas: An End Game of Eradication?
———————— Authors Schatman ME, Wegrzyn EL Received 8 October 2020 Accepted for publication 13 October 2020 Published 19 October 2020 Volume 2020:13 Pages 2629—2631 DOI https://doi.org/10.2147/JPR.S285835 Checked for plagiarism Yes Editor who approved publication: Dr E Alfonso Romero-Sandoval ————————-
Link to Original Article: https://test.dovepress.com/the-united-states-drug-enforcement-administration-and-prescription-opi-peer-reviewed-fulltext-article-JPR?fbclid=IwAR0i6Qt780PmrpBlmdzpP1Qn3EFaUOy3ocd9PjWjBEy3Z7mbwdLjw-O8SHU
iCareTalk.net 